2013, Number 2
<< Back Next >>
CorSalud 2013; 5 (2)
Report of a case with cardiac syndrome X or microvascular angina
Pérez ACR, Vega FLF, Valladares CFJ, Navarro LJJ, García CDA
Language: Spanish
References: 15
Page: 207-211
PDF size: 492.41 Kb.
ABSTRACT
The term cardiac syndrome X or microvascular angina is commonly used to describe a group of patients who show a typical chest pain, ST segment depression during exercise and angiographically normal coronary arteries. Many data suggest the symptoms may have an ischemic origin. It is more common in women, and, in almost 50% of them, anginal pain is specifically attributed to changes in the coronary microvasculature. The prognosis is not as benign as it was believed for years; therefore, in patients with angina and a normal epicardial coronary, a clinical and imaging assessment is necessary (including a careful analysis of risk factors) in order to detect a functionally significant ischemia. Therefore, coronary microvascular disease is a condition that requires attention by the attending physician. A patient with this diagnosis is reported in this article, and electrocardiographic, echocardiographic, ergometric and angiographic images are shown.
REFERENCES
Kaski CJ, Pérez Fernández R. Angina microvascular y síndrome X. Rev Esp Cardiol. 2002;55(Supl 1):10-6.
Peix González A. Isquemia miocárdica y enferme-dad coronaria microvascular. Rev Cubana Cardiol Cir Cardiovasc. 2010;16(3):264-75. Disponible en: http://bvs.sld.cu/revistas/car/vol16_3_10/car06310.pdf
Banksc K, Lo M, Khera A. Angina in Women without Obstructive Coronary Artery Disease. Curr Cardiol Rev. 2010;6(1):71-81.
Sakr SA, Abbas TM, Amer MZ, Dawood EM, El-Shahat N, Abdel Aal IA, et al. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J. 2009;50(4): 407-19.
Singh M, Singh S, Arora R, Kosla S. Cardiac syn-drome X: Current conceps. Int J Cardiol. 2010;142; (2):113-9.
Kaski JC, Iqbal K. Cardiac syndrome X: pathogenesis and management. Heart Metab. 2008;40:30-5.
Blasco Morillas P, Frutos García A, Bertomeu Martí-nez V, Valero Parra R, Rodríguez Ortega JA. Efectos de la Trimetazidina en la angina microvascular de origen hipertensivo. Hipertensión. 2001;18(8):389-92.
Fogoros RN. Cardiac syndrome X (CSX). Angina with normal coronary arteries [Internet]. 2011 [citado 4 Nov 2012]. Disponible en: http://heartdisease.about.com/cs/coronarydisease/a/CSX.htm
Vesely MR, Dilsizian V. Microvascular angina: assessment of coronary blood flow, flow reserve, and metabolism. Curr Cardiol Rep. 2011;13(2):151-8.
10.Larsen W, Mandleco B. Chest pain with angio-graphic clear coronary arteries: A provider's approach to cardiac syndrome X. J Am Acad Nurse Pract. 2009;21(7):371-6.
11.Yaghoubi M, Arefi SH, Assadi M. Comparison of angiographic with myocardial perfusion scinti-graphy findings in cardiac syndrome X (CSX). Eur Rev Med Pharmacol Sci. 2011;15(12):1385-8.
12.Parsyan A, Pilote L. Cardiac syndrome X: mystery continues. Can J Cardiol. 2012;28(2 Suppl):S3-6.
13.Arthur HM, Campbell P, Harvey PJ, McGillion M, Oh P, Woodburn E, et al. Women, cardiac syndrome X, and microvascular heart disease. Can J Cardiol.2012;28(2 Suppl):S42-9.
14.Hong HC, Lee DH, Lee SH, Joo SB. TIMI frame count versus thermodilution: diagnosing microvascular angina in cardiac syndrome X. Int J Cardiol. 2012;157(1):137-9.
15.Letić M. Asymptomatic microvascular angina? Am J Cardiol. 2012;110(9):1386.